INDIGENT CARE MANAGEMENT PROGRAM BY NATIONAL HEALTH COUNCIL/S&FA WOULD LIMIT FINANCIAL EXPOSURE OF INDIVIDUAL MANUFACTURERS; JANUARY DEBUT PLANNED
Executive Summary
The National Health Council is proposing a centrally-administered program for patient drug assistance programs that would provide manufacturers with an option to cap their annual financial exposure. NHC is proposing the program in conjunction with Parexel's S&FA subsidiary, an Alexandria, Va.-based company already participating in the management of individual patient assistance programs.